P, N., & K, V. (2019). Development of anti-HER2-targeted doxorubicin–core-shell chitosan nanoparticles for the treatment of human breast cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationP, Naruphontjirakul, and Viravaidya-Pasuwat K. Development of Anti-HER2-targeted Doxorubicin–core-shell Chitosan Nanoparticles for the Treatment of Human Breast Cancer. Dove Medical Press, 2019.
MLA (8th ed.) CitationP, Naruphontjirakul, and Viravaidya-Pasuwat K. Development of Anti-HER2-targeted Doxorubicin–core-shell Chitosan Nanoparticles for the Treatment of Human Breast Cancer. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.